When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in early-stage funding to develop better drugs for pharmaceutical companies and open up ...

Researchers from Seoul National University Hospital have designed a machine learning model that predicts an individual's likely response to an anticonvulsant drug, aiming to reduce trials and errors ...

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on drug discovery and research available to the broader healthcare industry, ...

Using artificial intelligence to create new drugs may be the technology’s most important and marketable use. The idea isn’t merely hypothetical anymore, either. It’s now commercialized, even if still ...